94 related articles for article (PubMed ID: 20467892)
1. Methylenetetrahydrofolate reductase C677T polymorphism in breast cancer risk.
Eroğlu A; Akar N
Breast Cancer Res Treat; 2010 Aug; 122(3):897-8. PubMed ID: 20467892
[No Abstract] [Full Text] [Related]
2. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
[TBL] [Abstract][Full Text] [Related]
3. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Langsenlehner T; Renner W; Yazdani-Biuki B; Langsenlehner U
Breast Cancer Res Treat; 2008 Feb; 107(3):459-60. PubMed ID: 17453338
[TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Macis D; Maisonneuve P; Johansson H; Bonanni B; Botteri E; Iodice S; Santillo B; Penco S; Gucciardo G; D'Aiuto G; Rosselli Del Turco M; Amadori M; Costa A; Decensi A
Breast Cancer Res Treat; 2007 Dec; 106(2):263-71. PubMed ID: 17260091
[TBL] [Abstract][Full Text] [Related]
5. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype.
Grieu F; Powell B; Beilby J; Iacopetta B
Anticancer Res; 2004; 24(5B):3215-9. PubMed ID: 15510613
[TBL] [Abstract][Full Text] [Related]
7. Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer.
Cam R; Eroglu A; Egin Y; Akar N
Breast Cancer Res Treat; 2009 May; 115(2):431-2. PubMed ID: 18498051
[No Abstract] [Full Text] [Related]
8. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
[TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis.
Zintzaras E
Clin Genet; 2006 Apr; 69(4):327-36. PubMed ID: 16630166
[TBL] [Abstract][Full Text] [Related]
10. Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer.
Martin YN; Olson JE; Ingle JN; Vierkant RA; Fredericksen ZS; Pankratz VS; Wu Y; Schaid DJ; Sellers TA; Weinshilboum RM
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2322-4. PubMed ID: 17119067
[No Abstract] [Full Text] [Related]
11. The MTHFR C677T polymorphism, estrogen exposure and breast cancer risk: a nested case-control study in Taiwan.
Lin WY; Chou YC; Wu MH; Huang HB; Jeng YL; Wu CC; Yu CP; Yu JC; You SL; Chu TY; Chen CJ; Sun CA
Anticancer Res; 2004; 24(6):3863-8. PubMed ID: 15736423
[TBL] [Abstract][Full Text] [Related]
12. Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene.
Beilby J; Ingram D; Hähnel R; Rossi E
Eur J Cancer; 2004 May; 40(8):1250-4. PubMed ID: 15110890
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
[TBL] [Abstract][Full Text] [Related]
14. Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population.
Deligezer U; Akisik EE; Dalay N
In Vivo; 2005; 19(5):889-93. PubMed ID: 16097444
[TBL] [Abstract][Full Text] [Related]
15. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review.
Boccia S; Hung R; Ricciardi G; Gianfagna F; Ebert MP; Fang JY; Gao CM; Götze T; Graziano F; Lacasaña-Navarro M; Lin D; López-Carrillo L; Qiao YL; Shen H; Stolzenberg-Solomon R; Takezaki T; Weng YR; Zhang FF; van Duijn CM; Boffetta P; Taioli E
Am J Epidemiol; 2008 Mar; 167(5):505-16. PubMed ID: 18162478
[TBL] [Abstract][Full Text] [Related]
16. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer.
Boccia S; Boffetta P; Brennan P; Ricciardi G; Gianfagna F; Matsuo K; van Duijn CM; Hung RJ
Cancer Lett; 2009 Jan; 273(1):55-61. PubMed ID: 18789576
[TBL] [Abstract][Full Text] [Related]
17. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiński J; Scott RJ; Hamann U
Breast Cancer Res Treat; 2007 Sep; 104(3):299-308. PubMed ID: 17063264
[TBL] [Abstract][Full Text] [Related]
18. [Study on the relations between genetic polymorphisms in methylenetetrahydrofolate reductase, methionine synthase and the risk of pancreatic cancer].
Wang L; Lin DX; Lu XH; Miao XP; Li H
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Jan; 27(1):50-4. PubMed ID: 16737574
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer.
Zeybek U; Yaylim I; Yilmaz H; Ağaçhan B; Ergen A; Arikan S; Bayrak S; Isbir T
Cell Biochem Funct; 2007; 25(4):419-22. PubMed ID: 16927418
[TBL] [Abstract][Full Text] [Related]
20. The C677T polymorphism of the methylenetetrahydrofolate reductase gene is associated with idiopathic ischemic stroke in the young Mexican-Mestizo population.
Isordia-Salas I; Barinagarrementería-Aldatz F; Leaños-Miranda A; Borrayo-Sánchez G; Vela-Ojeda J; García-Chávez J; Ibarra-González I; Majluf-Cruz A
Cerebrovasc Dis; 2010; 29(5):454-9. PubMed ID: 20203488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
